Pharmacological inhibition of the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; often known as FRAP-linked protein (FRP1)) has emerged like a promising strategy for most cancers procedure that exploits synthetic lethal interactions with proteins linked to DNA injury mend, overcomes resistance to other therapies and improves antitumour immunity. Multiple https://shanebobnz.blogmazing.com/26446736/azd4547-an-overview